EyeGene,Inc
Develops gene/cell therapies for age-related diseases and preventive vaccines.
185490 | KO
Overview
Corporate Details
- ISIN(s):
- KR7185490000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 의왕시 양지편2로 13 2층, 의왕시
- Website:
- https://eyegene.co.kr/en/
Description
EyeGene, Inc. is a clinical-stage biopharmaceutical company that researches and develops innovative therapeutics, with a primary focus on gene and cell therapy for age-related diseases. The company's pipeline includes EG-Mirotin, a treatment candidate for non-proliferative diabetic retinopathy and dry age-related macular degeneration. EyeGene is also developing preventive vaccines, such as EG-HPV for cervical cancer, utilizing its proprietary EG-Vac adjuvant system to enhance vaccine efficacy. The company is dedicated to creating transformative treatments by advancing biomedical science.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-24 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.2 KB | ||
| 2025-02-24 00:00 |
주주총회소집결의
|
Korean | 12.1 KB | ||
| 2025-02-10 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.0 KB | ||
| 2024-12-10 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 1.0 MB | ||
| 2024-11-01 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청) (4가 수막구균 접합백신 ‘EG-MCV4'의 국내 임상 3상 임상시험계획 …
|
Korean | 8.7 KB | ||
| 2024-09-30 00:00 |
주식매수선택권부여에관한신고
|
Korean | 15.5 KB | ||
| 2024-08-14 00:00 |
반기보고서 (2024.06)
|
Korean | 1.0 MB | ||
| 2024-05-16 00:00 |
분기보고서 (2024.03)
|
Korean | 1.0 MB | ||
| 2024-05-08 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 93.4 KB | ||
| 2024-04-11 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.3 KB | ||
| 2024-04-05 00:00 |
본점소재지변경
|
Korean | 5.0 KB | ||
| 2024-03-26 00:00 |
정기주주총회결과
|
Korean | 21.6 KB | ||
| 2024-03-18 00:00 |
감사보고서제출
|
Korean | 25.7 KB | ||
| 2024-03-18 00:00 |
사업보고서 (2023.12)
|
Korean | 377.7 KB |
Automate Your Workflow. Get a real-time feed of all EyeGene,Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EyeGene,Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EyeGene,Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
